Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
- PMID: 31321025
- PMCID: PMC6610726
- DOI: 10.1155/2019/4274315
Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
Abstract
[This retracts the article DOI: 10.1155/2013/234683.].
Retraction of
-
Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes.Malar Res Treat. 2013;2013:234683. doi: 10.1155/2013/234683. Epub 2013 Dec 15. Malar Res Treat. 2013. Retraction in: Malar Res Treat. 2019 Jun 20;2019:4274315. doi: 10.1155/2019/4274315. PMID: 24455414 Free PMC article. Retracted.
References
-
- Ali I. M., Netongo P. M., Barbara A.-T., et al. Amodiaquine-artesunate versus artemether-lumefantrine against uncomplicated malaria in children less than 14 years in Ngaoundere, North Cameroon: efficacy, safety, and baseline drug resistant mutations in pfcrt, pfmdr1, and pfdhfr Genes. Malaria Research and Treatment. 2013;2013:10. doi: 10.1155/2013/234683.234683 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
